Joint hypermobility syndrome is characterized by joints that move beyond normal ranges and can lead to pain, often inherited alongside Ehlers-Danlos syndrome (EDS), which affects collagen synthesis and leads to various physical manifestations. Management strategies for these conditions include medications, physiotherapy, and potentially surgery, while benign joint hypermobility syndrome typically requires minimal intervention. Marfan syndrome, another connective tissue disorder, presents with unique physical features and also necessitates a tailored treatment approach to manage its systemic effects.